Emergency Department, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Department II of Neurology, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Eur J Neurol. 2024 Dec;31(12):e16481. doi: 10.1111/ene.16481. Epub 2024 Sep 17.
This study aims to examine the global, regional, and national burden of ischemic stroke from 1990 to 2021.
We used data from the Global Burden of Disease (GBD) 2021 database to comprehensively assess ischemic stroke indicators globally, regionally, and in 204 countries, including incidence, deaths, disability-adjusted life years (DALYs), estimated annual percentage change (EAPC), and Joinpoint regression analysis.
In 2021, there were a total of 7,804,449 cases of ischemic stroke globally (95% uncertainty interval = 6,719,760-8,943,692), with an age-standardized incidence rate (ASIR) of 92.39. This represents a declining trend compared to 1990, with an EAPC of -0.67 (95% confidence interval [CI] = -0.76 to -0.58). Mortality and DALY rates also showed a downward trend (EAPC in age-standardized mortality rate: -1.83, 95% CI = -1.92 to -1.74; EAPC in age-standardized DALY rate = -1.59, 95% CI = -1.68 to -1.50). The burden of ischemic stroke was inversely correlated with gross domestic product. Regionally, from 2014 to 2021, the Caribbean experienced the fastest increase in ASIR (annual percent change = 0.15, 95% CI = 0.13 to 0.18). Among 204 countries, North Macedonia had the highest incidence, mortality, and DALY rates. In addition to metabolic risks, particulate matter pollution and low temperatures were significant environmental and occupational risk factors for ischemic stroke. Smoking and a diet high in sodium were identified as key behavioral risk factors.
Ischemic stroke remains a serious global health challenge, and our results from this cross-sectional study suggest that the burden of disease remains high in Eastern Europe, East Asia, Central Asia, and Sub-Saharan Africa.
本研究旨在评估 1990 年至 2021 年期间全球、区域和国家缺血性卒中的负担。
我们使用来自全球疾病负担(GBD)2021 数据库的数据,全面评估了全球、区域和 204 个国家的缺血性卒中指标,包括发病率、死亡率、残疾调整生命年(DALY)、估计年变化百分比(EAPC)和 Joinpoint 回归分析。
2021 年,全球共有 7804449 例缺血性卒中病例(95%不确定性区间=6719760-8943692),年龄标准化发病率(ASIR)为 92.39。与 1990 年相比,这呈现出下降的趋势,EAPC 为-0.67(95%置信区间[CI]:-0.76 至-0.58)。死亡率和 DALY 率也呈下降趋势(年龄标准化死亡率 EAPC=-1.83,95%CI=-1.92 至-1.74;年龄标准化 DALY 率 EAPC=-1.59,95%CI=-1.68 至-1.50)。缺血性卒中负担与国内生产总值呈负相关。区域上,从 2014 年到 2021 年,加勒比地区的 ASIR 增长最快(年变化率=0.15,95%CI=0.13 至 0.18)。在 204 个国家中,北马其顿的发病率、死亡率和 DALY 率最高。除代谢风险外,颗粒物污染和低温也是缺血性卒中的重要环境和职业风险因素。吸烟和高钠饮食被确定为关键的行为风险因素。
缺血性卒中仍然是全球严重的健康挑战,我们的横断面研究结果表明,东欧、东亚、中亚和撒哈拉以南非洲的疾病负担仍然很高。